|
TRPM7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.6683999999989E-05 |
| Normal-vs-Stage3 |
8.88178419700125E-16 |
| Normal-vs-Stage4 |
1.65512048511118E-12 |
| Stage1-vs-Stage2 |
1.540590E-01 |
| Stage1-vs-Stage3 |
5.662400E-02 |
| Stage1-vs-Stage4 |
1.460160E-02 |
| Stage2-vs-Stage3 |
1.022340E-02 |
| Stage2-vs-Stage4 |
4.124700E-03 |
| Stage3-vs-Stage4 |
3.802400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
4.12659995063791E-09 |
| Normal-vs-Asian |
1.279499994844E-08 |
| Caucasian-vs-AfricanAmerican |
4.710000E-01 |
| Caucasian-vs-Asian |
2.154400E-01 |
| AfricanAmerican-vs-Asian |
1.343390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87883042457315E-12 |
| Normal-vs-Female |
1.62470037423645E-12 |
| Male-vs-Female |
4.125600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63002944475465E-12 |
| Normal-vs-Age(41-60Yrs) |
1.99840144432528E-15 |
| Normal-vs-Age(61-80Yrs) |
1.80555570494789E-12 |
| Normal-vs-Age(81-100Yrs) |
2.25969999999576E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.339600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.788400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.195000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.956200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.272600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.672600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.038830E-01 |
| Classical-VS-Follicular |
5.320600E-03 |
| Classical-VS-Other |
7.163600E-01 |
| Classical-VS-Normal |
3.75943720598571E-12 |
| Tall-VS-Follicular |
5.604300E-04 |
| Tall-VS-Other |
2.095600E-01 |
| Tall-VS-Normal |
4.57933690967138E-12 |
| Follicular-VS-Other |
5.392400E-01 |
| Follicular-VS-Normal |
3.6098000000262E-06 |
| Other-VS-Normal |
3.957500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.42534897615587E-13 |
| Normal-vs-N1 |
7.48845430109668E-13 |
| N0-vs-N1 |
6.993600E-02 |
|
|
